My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Medipharm Labs Corp (OP:MEDIF)

0.0570 -0.0033 (-5.47%)

Streaming Delayed Price Updated: 10:01 AM EDT, May 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Medipharm Labs Corp

< Previous 1 2 3 4 Next >

This Week In Cannabis: America's Crackdown Down On Hemp, Global Reform, Industry Gathering In Chicago ↗

June 06, 2025

Congress advances hemp THC ban as cannabis leaders prep for Benzinga's Chicago conference. Global markets shift. Here's the full recap.

Via Benzinga

Topics Cannabis

This Week In Cannabis: Trump Policy Updates, Corporate Moves, Regulatory Shifts And Product Innovations ↗

April 04, 2025

This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.

Via Benzinga

Topics Government

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth ↗

November 14, 2024

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024...

Via Benzinga

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q2 2024 ↗

August 14, 2024

MediPharm Labs just reported results for the second quarter of 2024.

Via InvestorPlace

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q1 2024 ↗

May 15, 2024

MediPharm Labs just reported results for the first quarter of 2024.

Via InvestorPlace

MEDIF Stock Earnings: MediPharm Labs Reported Results for Q4 2023 ↗

March 27, 2024

MediPharm Labs just reported results for the fourth quarter of 2023.

Via InvestorPlace

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY ↗

August 14, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an...

Via Benzinga

Topics Cannabis

The Canadian Cannabis Report- Monday, Aug 12 ↗

August 13, 2024

The past, present and future of the Canadian cannabis sector.

Via Talk Markets

Topics Cannabis

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now ↗

August 09, 2024

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024,...

Via Benzinga

Topics Cannabis

Executive Changes In Cannabis Industry You Should Know About, New Appointments & More ↗

July 03, 2024

Shareholders of four cannabis companies held their respective annual meetings, electing nominees as board directors.Sandy Li, who has been serving at cannabis edibles producer Wana Brands since 2022 as...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused MediPharm Boasts This Advanced Medical Cannabis Delivery Method ↗

June 20, 2024

Cannabinoids-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday that it has entered into a licensing agreement with Remidose Aerosols Inc. to...

Via Benzinga

Topics Cannabis

Cannabinoids-Focused Pharma Company, MediPharm, Sees Higher Q1 Revenue, CFO Touts 'Strong Financial Position' ↗

May 15, 2024

Via Benzinga

The Canadian Cannabis Report - Monday, April 22 ↗

April 22, 2024

The past, present and future of the Canadian cannabis sector, based on the performanceof the MCCCI, which is a proprietary index of 14 stocks.

Via Talk Markets

Topics Cannabis

This Cannabinoids-Focused Pharma Co. Sees 50% YoY Surge In Revenue In 2023, Trims Losses ↗

March 27, 2024

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday its financial results for the full year and three months ended Dec. 31,...

Via Benzinga

The Canadian Cannabis Report - Monday, March 25 ↗

March 27, 2024

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 14 stocks

Via Talk Markets

Topics Cannabis

Canadian CBD-Focused Pharma Co. Gets Green Light To Produce Medical Marijuana In Brazil ↗

February 07, 2024

Canada's MediPharm Labs has received a GMP certification from the Brazilian governing body, ANVISA. The approval allows for the production of active pharmaceutical ingredients (APIs) and end products...

Via Benzinga

Topics Cannabis

Key Leadership Changes In Cannabis You Should Know About As We Head Into 2024 ↗

December 22, 2023

This month, the Indigenous Cannabis Industry Association held its first Indigenous Cannabis Regulators roundtable, bringing together Indigenous Cannabis Regulators from Tribal Nations and...

Via Benzinga

Topics Cannabis

MediPharm Labs Still Hits C$8.5M Despite Sequential Drop, More On That In Q3 2023 Financial Report ↗

November 14, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) reported its financial results for the three months ended September 30, 2023, with a revenue of C$8.5 million. This reflects a decrease of...

Via Benzinga

New Cannabis Products Energize Global Health & Wellness Market, Including Australia ↗

October 16, 2023

In the ever-evolving world of cannabis products, innovation is the name of the game for those in search of health and wellness solutions.

Via Benzinga

Topics Cannabis

MediPharm Settles Commercial Agreement Dispute With Tilray's Hexo For $9M ↗

October 02, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) entered into a settlement agreement on September 29, 2023 to resolve a claim in connection with a commercial agreement dis

Via Benzinga

New CBD & THC Cannabis Oils Now Shipping To Australia From Canada ↗

September 28, 2023

MediPharm Labs Corp.

Via Benzinga

Topics Cannabis

The Canadian Cannabis Report - Monday, Sept. 25 ↗

September 25, 2023

The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietarey index of 15 stocks.

Via Talk Markets

Topics Cannabis

MediPharm Labs Breaks Free From Royalty Agreement, What It Means & What's Next ↗

September 20, 2023

MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) has executed a supplementary agreement to its asset purchase agreement with 1193269 B.C.

Via Benzinga

Could Medical Cannabis Be The Answer For Fibromyalgia? Here's What New Study Found ↗

August 31, 2023

New research has shown that medical cannabis may effectively manage fibromyalgia and associated symptoms of depression and anxiety.

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From August 24, 2023 ↗

August 24, 2023

Via Benzinga

Topics Cannabis

Marijuana Stock Movers For August 23, 2023 ↗

August 23, 2023

Via Benzinga

Topics Cannabis

Cannabinoid-Focused Pharma Stock Slides On Q2 Earnings Report, Here Are The Details ↗

August 14, 2023

Cannabinoid-focused pharmaceutical company MediPharm Labs Corp.

Via Benzinga

Cannabis Stock Gainers And Losers From August 16, 2023 ↗

August 16, 2023

Via Benzinga

Topics Cannabis

Marijuana Stock Movers For August 15, 2023 ↗

August 15, 2023

Via Benzinga

Topics Cannabis

Cannabis Stock Gainers And Losers From August 14, 2023 ↗

August 14, 2023

Via Benzinga

Topics Cannabis

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition